Candel Therapeutics (CADL) Competitor Comparison
We are evaluating the key criteria listed to compare Candel Therapeutics (CADL) against its competitors in the Biotechnology industry.
Market Capitalization
293 / 368Gross Profits
174 / 278Total Revenue
278 / 300EBITDA
119 / 337Free Cashflow
143 / 352Quick Ratio
209 / 357Earnings per Share
186 / 359Dividend yield
0 / 6Total Cash
266 / 358Performance 3 years
186 / 368Performance 5 years
172 / 368Performance 10 years
143 / 368Linearity 3 years
193 / 368Linearity 5 years
98 / 368Linearity 10 years
94 / 368Total Rank
299 / 368Dividend Rank
74 / 368Valuation Rank
100 / 368Piotroski Rank
325 / 368Muliplier Rank
301 / 368Dividend yield - CADL ranking 0 / 6
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.